Cargando…
Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection
BACKGROUND: Hepatic resection is the preferred treatment for huge hepatocellular carcinoma (>10 cm in diameter; H-HCC). However, the patients with H-HCC suffer from poor prognosis due to the early recurrence/metastasis. The underlying mechanism of H-HCC’s early recurrence/metastasis is currently...
Autores principales: | Huang, Xinhui, Zeng, Yongyi, Xing, Xiaohua, Zeng, Jinhua, Gao, Yunzhen, Cai, Zhixiong, Xu, Bo, Liu, Xiaolong, Huang, Aimin, Liu, Jingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023177/ https://www.ncbi.nlm.nih.gov/pubmed/24839399 http://dx.doi.org/10.1186/1477-5956-12-22 |
Ejemplares similares
-
Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014) -
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019) -
Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesions
por: Xing, Xiaohua, et al.
Publicado: (2015) -
The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis
por: Wang, Lei, et al.
Publicado: (2017) -
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)